Faculty profile

Adriana Luk

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Adriana Luk

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
19 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

343

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).
Circulation. Heart failure · 2026
Young adults in the cardiac intensive care unit: insights from the Critical Care Cardiology Trials Network registry.
European heart journal. Acute cardiovascular care · 2026
Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock.
Critical care (London, England) · 2026

All 31 publications

31 publications.

Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).

Hamilton DE, Shriver JL, Patel SM, Park JG, Michos ZE, Mathis MR, Adie SK, Alviar CL, Barnett CF, Berg DD, Bennett CE, Bohula EA, Carnicelli AP, Daniels LB, Dodson MW, Gage A, Gidwani U, Goldfarb M, Katz JN, Ketcham SW, Kwon Y, Leibner ES, Loriaux DB, Luk A, Marano P, Miller PE, Mukundan SV, Papolos AI, Pisani BA, Proudfoot AG, Roswell RO, Shah KS, Solomon MA, Tomey MI, van Diepen S, Zakaria S, Morrow DA, Thompson AD, CCCTN Investigators

Circulation. Heart failure20262 citationsOpen Access

DOI: 10.1161/circheartfailure.125.013778 PMID: 42093634

Young adults in the cardiac intensive care unit: insights from the Critical Care Cardiology Trials Network registry.

Isath A, Sharma T, Mahmood U, Smith D, Berg DD, Bohula EA, Chaudhry SP, Daniels LB, Ding X, Fordyce CB, Gerber D, Goldfarb M, Guo J, Kontos MC, Liu S, Luk A, Menon V, Patel SM, Roswell RO, Morrow DA, Cooper HA

European heart journal. Acute cardiovascular care20261 citationsOpen Access

DOI: 10.1093/ehjacc/zuaf161 PMID: 41416463

Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock.

Marinho LL, Lileikyte G, Boileau P, Lu Y, Churpek M, Spicer A, Harhay M, Chen Z, Luk A, Zampieri FG, Tavares CAM, Proudfoot A, Pop C, Deschênes PJF, Zarychanzki R, Lother S, Abrahão Hajjar L, Jentzer JC, van Diepen S, di Santo P, Mathew R, Lawler PR

Critical care (London, England)2026Open Access

DOI: 10.1186/s13054-026-05938-6 PMID: 42298588

Perioperative Management: HeartMate 3 Left Ventricular Assist Devices in Non-Cardiac Surgery.

O'Callaghan L, Walsh D, Mulligan D, Merdad M, Luk A, Billia F, Rao V, Wasowicz M, Griffin M, Efrimescu C

Journal of cardiothoracic and vascular anesthesia2026

DOI: 10.1053/j.jvca.2026.05.011 PMID: 42270552

ECLS-SHOCK and DanGer Shock: Implications for Optimal Temporary Mechanical Circulatory Support Use for Cardiogenic Shock Due to Acute Myocardial Infarction

Luk A, Barker M, Billia P, Fordyce CB, So D, Tsang M, Potter BJ

Canadian Journal of Cardiology20253 citationsFirst author

DOI: 10.1016/j.cjca.2025.01.007

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care

van Diepen S, Le May MR, Alfaro P, Goldfarb MJ, Luk A, Mathew R, Peretz-Larochelle M, Rayner-Hartley E, Russo JJ, Senaratne JM

Canadian Journal of Cardiology202420 citationsOpen Access

DOI: 10.1016/j.cjca.2024.01.012 PMID: W4394572563

Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry

Réa ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, Scolari FL, Wang VN, Nisar M, Fung NL, Otsuki M, Billia F

Canadian Journal of Cardiology202416 citationsSenior author

DOI: 10.1016/j.cjca.2023.12.005

Value of Invasive Hemodynamic Assessments in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.

Rodenas-Alesina E, Brahmbhatt DH, Mak S, Ross HJ, Luk A, Rao V, Billia F

JACC. Heart failure20248 citationsOpen Access

DOI: 10.1016/j.jchf.2023.08.019 PMID: 37804313

Implications of High Sensitivity Troponin Levels After Lung Transplantation

Rodenas-Alesina E, Luk A, Gajasan J, Alhussaini A, Martel G, Serrick C, McRae K, Overgaard C, Cypel M, Singer L

Transplant International20242 citationsOpen Access

DOI: 10.3389/ti.2024.12724

Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement

Panel P, Fordyce CB, Kramer AH, Ainsworth C, Christenson J, Hunter G, Kromm J, Soto CL, Scales DC, Sekhon M

Canadian Journal of Cardiology202340 citationsOpen Access

DOI: 10.1016/j.cjca.2022.12.014

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Adriana Luk

Research

Latest papers

Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).

Young adults in the cardiac intensive care unit: insights from the Critical Care Cardiology Trials Network registry.

Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock.

Perioperative Management: HeartMate 3 Left Ventricular Assist Devices in Non-Cardiac Surgery.

ECLS-SHOCK and DanGer Shock: Implications for Optimal Temporary Mechanical Circulatory Support Use for Cardiogenic Shock Due to Acute Myocardial Infarction

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care

Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry

Value of Invasive Hemodynamic Assessments in Patients Supported by&#xa0;Continuous-Flow Left Ventricular Assist Devices.

Implications of High Sensitivity Troponin Levels After Lung Transplantation

Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement

Frequent collaborators

Jagdish Butany

Filio Billia

Christopher Fordyce

Sean Van Diepen

Christopher Overgaard

Shuangbo Liu

Vivek Rao

Derek So

Vesna Mihajlovic

Michael Goldfarb

Rebecca Mathew

Susanna Mak

Craig Ainsworth

Michel Le May

Akshay Bagai

Julie Kromm

Anhar Alhussaini

Mena Gewarges

Shaun Goodman

Emilie Belley-Cote

Patrick Lawler

Michael McDonald

Mitesh Badiwala

Osami Honjo

Jane Heggie

Marjan Jariani

Gary Hunter

Victoria McCredie

Philippe Boileau

Value of Invasive Hemodynamic Assessments in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.